Cargando…

A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment

BACKGROUND: In resource-poor settings, mortality is at its highest during the first 3 months after combination antiretroviral treatment (cART) initiation. A clear predictor of mortality during this period is having a low CD4 count at the time of treatment initiation. The objective of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Braitstein, Paula, Siika, Abraham, Hogan, Joseph, Kosgei, Rose, Sang, Edwin, Sidle, John, Wools-Kaloustian, Kara, Keter, Alfred, Mamlin, Joseph, Kimaiyo, Sylvester
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297518/
https://www.ncbi.nlm.nih.gov/pubmed/22340703
http://dx.doi.org/10.1186/1758-2652-15-7
_version_ 1782225879006445568
author Braitstein, Paula
Siika, Abraham
Hogan, Joseph
Kosgei, Rose
Sang, Edwin
Sidle, John
Wools-Kaloustian, Kara
Keter, Alfred
Mamlin, Joseph
Kimaiyo, Sylvester
author_facet Braitstein, Paula
Siika, Abraham
Hogan, Joseph
Kosgei, Rose
Sang, Edwin
Sidle, John
Wools-Kaloustian, Kara
Keter, Alfred
Mamlin, Joseph
Kimaiyo, Sylvester
author_sort Braitstein, Paula
collection PubMed
description BACKGROUND: In resource-poor settings, mortality is at its highest during the first 3 months after combination antiretroviral treatment (cART) initiation. A clear predictor of mortality during this period is having a low CD4 count at the time of treatment initiation. The objective of this study was to evaluate the effect on survival and clinic retention of a nurse-based rapid assessment clinic for high-risk individuals initiating cART in a resource-constrained setting. METHODS: The USAID-AMPATH Partnership has enrolled more than 140,000 patients at 25 clinics throughout western Kenya. High Risk Express Care (HREC) provides weekly or bi-weekly rapid contacts with nurses for individuals initiating cART with CD4 counts of ≤100 cells/mm(3). All HIV-infected individuals aged 14 years or older initiating cART with CD4 counts of ≤100 cells/mm(3 )were eligible for enrolment into HREC and for analysis. Adjusted hazard ratios (AHRs) control for potential confounding using propensity score methods. RESULTS: Between March 2007 and March 2009, 4,958 patients initiated cART with CD4 counts of ≤100 cells/mm(3). After adjusting for age, sex, CD4 count, use of cotrimoxazole, treatment for tuberculosis, travel time to clinic and type of clinic, individuals in HREC had reduced mortality (AHR: 0.59; 95% confidence interval: 0.45-0.77), and reduced loss to follow up (AHR: 0.62; 95% CI: 0.55-0.70) compared with individuals in routine care. Overall, patients in HREC were much more likely to be alive and in care after a median of nearly 11 months of follow up (AHR: 0.62; 95% CI: 0.57-0.67). CONCLUSIONS: Frequent monitoring by dedicated nurses in the early months of cART can significantly reduce mortality and loss to follow up among high-risk patients initiating treatment in resource-constrained settings.
format Online
Article
Text
id pubmed-3297518
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-32975182012-03-09 A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment Braitstein, Paula Siika, Abraham Hogan, Joseph Kosgei, Rose Sang, Edwin Sidle, John Wools-Kaloustian, Kara Keter, Alfred Mamlin, Joseph Kimaiyo, Sylvester J Int AIDS Soc Research BACKGROUND: In resource-poor settings, mortality is at its highest during the first 3 months after combination antiretroviral treatment (cART) initiation. A clear predictor of mortality during this period is having a low CD4 count at the time of treatment initiation. The objective of this study was to evaluate the effect on survival and clinic retention of a nurse-based rapid assessment clinic for high-risk individuals initiating cART in a resource-constrained setting. METHODS: The USAID-AMPATH Partnership has enrolled more than 140,000 patients at 25 clinics throughout western Kenya. High Risk Express Care (HREC) provides weekly or bi-weekly rapid contacts with nurses for individuals initiating cART with CD4 counts of ≤100 cells/mm(3). All HIV-infected individuals aged 14 years or older initiating cART with CD4 counts of ≤100 cells/mm(3 )were eligible for enrolment into HREC and for analysis. Adjusted hazard ratios (AHRs) control for potential confounding using propensity score methods. RESULTS: Between March 2007 and March 2009, 4,958 patients initiated cART with CD4 counts of ≤100 cells/mm(3). After adjusting for age, sex, CD4 count, use of cotrimoxazole, treatment for tuberculosis, travel time to clinic and type of clinic, individuals in HREC had reduced mortality (AHR: 0.59; 95% confidence interval: 0.45-0.77), and reduced loss to follow up (AHR: 0.62; 95% CI: 0.55-0.70) compared with individuals in routine care. Overall, patients in HREC were much more likely to be alive and in care after a median of nearly 11 months of follow up (AHR: 0.62; 95% CI: 0.57-0.67). CONCLUSIONS: Frequent monitoring by dedicated nurses in the early months of cART can significantly reduce mortality and loss to follow up among high-risk patients initiating treatment in resource-constrained settings. The International AIDS Society 2012-02-17 /pmc/articles/PMC3297518/ /pubmed/22340703 http://dx.doi.org/10.1186/1758-2652-15-7 Text en Copyright ©2012 Braitstein et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Braitstein, Paula
Siika, Abraham
Hogan, Joseph
Kosgei, Rose
Sang, Edwin
Sidle, John
Wools-Kaloustian, Kara
Keter, Alfred
Mamlin, Joseph
Kimaiyo, Sylvester
A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment
title A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment
title_full A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment
title_fullStr A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment
title_full_unstemmed A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment
title_short A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment
title_sort clinician-nurse model to reduce early mortality and increase clinic retention among high-risk hiv-infected patients initiating combination antiretroviral treatment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297518/
https://www.ncbi.nlm.nih.gov/pubmed/22340703
http://dx.doi.org/10.1186/1758-2652-15-7
work_keys_str_mv AT braitsteinpaula acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT siikaabraham acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT hoganjoseph acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT kosgeirose acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT sangedwin acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT sidlejohn acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT woolskaloustiankara acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT keteralfred acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT mamlinjoseph acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT kimaiyosylvester acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT braitsteinpaula cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT siikaabraham cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT hoganjoseph cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT kosgeirose cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT sangedwin cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT sidlejohn cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT woolskaloustiankara cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT keteralfred cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT mamlinjoseph cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment
AT kimaiyosylvester cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment